drugset / Trial / NCT01607034

Study in Healthy Volunteers of the Bioavailability of Dexpramipexole Tablets and Food Effects

NCT01607034

Phase 1 Completed 24 enrolled Knopp Biosciences
RandomizedCrossoverOpen-labelTreatment

Summary

To assess the bioavailability of dexpramipexole when mixed in soft food and water, and in intact tablet form in the fasted and fed states in healthy volunteers.

Timeline

Start
2012-06
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexpramipexole Small molecule 150 mg Oral

Indications

No indication recorded.